+Follow
Dend
No personal profile
20
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
Dend
01-10
A chi
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3529802630439104","uuid":"3529802630439104","gmtCreate":1566708609262,"gmtModify":1566708609262,"name":"Dend","pinyin":"dend","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":20,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":3,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":261699567927464,"gmtCreate":1704902035142,"gmtModify":1704902039033,"author":{"id":"3529802630439104","authorId":"3529802630439104","name":"Dend","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3529802630439104","authorIdStr":"3529802630439104"},"themes":[],"htmlText":"A chi","listText":"A chi","text":"A chi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261699567927464","repostId":"2402996346","repostType":2,"repost":{"id":"2402996346","pubTimestamp":1704739196,"share":"https://ttm.financial/m/news/2402996346?lang=&edition=fundamental","pubTime":"2024-01-09 02:39","market":"us","language":"en","title":"CVS Health slips on rising medical costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2402996346","media":"seekingalpha","summary":"CVS Health traded lower, dragging down its managed care peers after the health insurer warned its medical costs for Q4 would exceed early forecasts. Notable decliners include Centene , Cigna , UnitedHealth Group , and Elevance Health . The owner of Aetna health insurer said that its medical benefits ratio, the share of premiums spent on medical costs, could exceed its previously projected target of 86% for 2023 based on early results for Q4. \"We've continued to see pressure\" in the healthcare benefits segment, newly appointed CFO Tom Cowhey remarked during a presentation at the JPMorgan Healthcare Conference in San Francisco. \"I would expect that you would see for 2023 that the MBR might exceed kind of that 86% that we had talked about based on where the fourth quarter is likely to land,\" he added. More on CVS Health J.P. Morgan 42nd Annual Healthcare Conference CVS Health Corporation 42nd Annual J.P. Morgan Healthcare Conference CVS Health: Shares Remain Modestly Undervalued,","content":"<html><body><ul> <li>CVS Health (<span>NYSE:CVS</span>) traded lower, dragging down its managed care peers after the health insurer warned its medical costs for Q4 would exceed early forecasts. </li> <li>Notable decliners include Centene (CNC), Cigna (CI), UnitedHealth Group (UNH), and <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> (ELV).</li> <li>The<span> owner of Aetna health insurer said that its medical benefits ratio, the share of premiums spent on medical costs, could exceed its previously projected target of 86% for 2023 based on early results for Q4.</span> </li> <li>\"We've continued to see pressure\" in the healthcare benefits segment, newly appointed CFO Tom Cowhey remarked during a presentation at the JPMorgan Healthcare Conference in San Francisco.</li> <li>\"I would expect that you would see for 2023 that the MBR might exceed kind of that 86% that we had talked about based on where the fourth quarter is likely to land,\" he added. </li> </ul> <div> <h2>More on CVS Health</h2> <ul> <li>J.P. Morgan 42nd Annual Healthcare Conference</li> <li>CVS Health Corporation (CVS) 42nd Annual J.P. Morgan Healthcare Conference (Transcript)</li> <li>CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength</li> <li>4 stocks to watch on Friday: <a href=\"https://laohu8.com/S/PYPL\">PayPal</a>, CVS Health, and more</li> <li>CVS Health reaffirms 2023 adjusted EPS guidance</li> </ul> </div></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CVS Health slips on rising medical costs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCVS Health slips on rising medical costs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-09 02:39 GMT+8 <a href=https://seekingalpha.com/news/4053179-cvs-health-stock-slips-rising-medical-costs><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CVS Health (NYSE:CVS) traded lower, dragging down its managed care peers after the health insurer warned its medical costs for Q4 would exceed early forecasts. Notable decliners include Centene (CNC)...</p>\n\n<a href=\"https://seekingalpha.com/news/4053179-cvs-health-stock-slips-rising-medical-costs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg","relate_stocks":{"BK4504":"桥水持仓","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","LU0251142724.SGD":"Fidelity America A-SGD","BK4127":"投资银行业与经纪业","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","CI":"信诺保险","CNC":"康西哥","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","LU0971096721.USD":"富达环球金融服务 A","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4532":"文艺复兴科技持仓","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","BK4534":"瑞士信贷持仓","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","ELV":"Elevance Health","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","MS":"摩根士丹利","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","UNH":"联合健康","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","SG9999001077.SGD":"United International Growth Fund SGD","BK4550":"红杉资本持仓","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","LU1670628061.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) INC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","BK4154":"管理型保健护理","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","CVS":"西维斯健康","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC"},"source_url":"https://seekingalpha.com/news/4053179-cvs-health-stock-slips-rising-medical-costs","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2402996346","content_text":"CVS Health (NYSE:CVS) traded lower, dragging down its managed care peers after the health insurer warned its medical costs for Q4 would exceed early forecasts. Notable decliners include Centene (CNC), Cigna (CI), UnitedHealth Group (UNH), and Elevance Health (ELV). The owner of Aetna health insurer said that its medical benefits ratio, the share of premiums spent on medical costs, could exceed its previously projected target of 86% for 2023 based on early results for Q4. \"We've continued to see pressure\" in the healthcare benefits segment, newly appointed CFO Tom Cowhey remarked during a presentation at the JPMorgan Healthcare Conference in San Francisco. \"I would expect that you would see for 2023 that the MBR might exceed kind of that 86% that we had talked about based on where the fourth quarter is likely to land,\" he added. More on CVS Health J.P. Morgan 42nd Annual Healthcare Conference CVS Health Corporation (CVS) 42nd Annual J.P. Morgan Healthcare Conference (Transcript) CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength 4 stocks to watch on Friday: PayPal, CVS Health, and more CVS Health reaffirms 2023 adjusted EPS guidance","news_type":1},"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":261699567927464,"gmtCreate":1704902035142,"gmtModify":1704902039033,"author":{"id":"3529802630439104","authorId":"3529802630439104","name":"Dend","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3529802630439104","authorIdStr":"3529802630439104"},"themes":[],"htmlText":"A chi","listText":"A chi","text":"A chi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261699567927464","repostId":"2402996346","repostType":2,"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
